We noticed you’re blocking ads

Thanks for visiting CRSTG | Europe Edition. Our advertisers are important supporters of this site, and content cannot be accessed if ad-blocking software is activated.

In order to avoid adverse performance issues with this site, please white list https://crstodayeurope.com in your ad blocker then refresh this page.

Need help? Click here for instructions.

Up Front | Oct 2007

Vryghem Macular Function Test

With a Parinaud chart and a trial lens, surgeons may predict visual outcomes with 94.2% sensitivity.

Potential vision tests before cataract surgery are essential to determine if surgery will produce visual improvements for the patient. The primary function of potential vision tests is to establish whether cataract is the only cause of visual impairment. If a patient is affected with retinal or corneal pathologies, visual recovery after phacoemulsification may be poor.

There are several methods to test potential vision. Retinal acuity may be predicted with tests including electroretinograpy,1-3 visual evoked potentials,1,2,4,5 color vision tests,6 blue-field entoptic tests,7-9 and B-scan ultrasonography.2 Other tests, which are discussed in this article round-up, include potential acuity meter assessment, retinal acuity meter assessment, and critical flicker/fusion frequency.

In the past, some potential vision test methods employed entoptic phenomena, however, these were not sensitive enough to distinguish the degree of visual impairment. Since 1993, I have used an inexpensive method of potential visual acuity measurement, which I named the Vryghem Macular Function Test. We found this method to boast a 94.2% sensitivity and a 32.4% specificity. This test also had a positive predictive value of 99.2%, a negative predictive value of 24.3%, and a BCVA of 20/30.

The only tools needed for the test are a Parinaud near reading chart (Figure 1), a trial lens of 8.00 D, and a Heine ophthalmoscope (Heine Optotechnik, Herrsching, Germany). The test is easy to conduct. First, position the Parinaud optotype letter chart approximately 12 cm from the trial lens, with the best correction for long distances and a hyperaddition of 8.00 D in the trial frame. Then, ask the patient to read the letter chart while illuminating the lines with a Heine ophthalmoscope.

The distance from the chart to the patient's eyes is important, and patients should move the chart themselves. Ask them to read the smallest numbers on the chart (grade Parinaud 1). Those who can read this line are given a positive score, as it is assumed that their macular function is good. Those who cannot read the smallest numbers on the chart should receive a negative score, indicating that their macular function is bad or beyond evaluation. In these patients, it is likely that their BCVA would be worse than 20/30.

We routinely use the Vryghem Macular Function Test preoperatively, during our clinical evaluation of a cataract patient. We base our decision to proceed with surgery on the outcome of the macular function test as well as the clinical evaluation, which includes cataract grading, distance BCVA, slit-lamp evaluation, applanation tonometry, and fundoscopy. If patients have posterior subcapsular plaque or a dense nuclear cataract, the test can be repeated after dilation of their pupils with phenylephrine 15% and tropicamide.

From September 2000 to February 2001, we conducted a prospective study of 396 patients (128 male and 268 female) in whom I performed cataract surgery.10 Of these patients, 37 were not able to read Parinaud 1 before surgery. Of the 359 patients (90.75%) who could read Parinaud 1, 94.2% had a postoperative BCVA of 20/25 or better and 99.2% had a BCVA of 20/30 or better, which was the positive predictive value of the test. Of patients who could not read Parinaud 1, 67.6% and 75.7% had a postoperative BCVA of 20/35 and 20/30 or better, respectively. Thus, the respective negative predictive values were 32.4% and 24.3%. The Vryghem Macular Function Test yielded a high positive predictive value and sensitivity, but a low specificity and negative predictive value. Of the 25 patients who could not read Parinaud 1, but attained a postoperative BCVA of 20/25 or better, 18 had a nuclear or subcapsular cataract of a density that made it impossible to read that line. (See Figure 1 for more details.)

We concluded that the Vryghem Macular Function Test is 99.2% accurate. If the test proves positive, the surgeon may assume that the patient's macular function is adequate, which indicates that good visual outcomes will result after cataract surgery. If the result is negative—indicating poor macular function—the chance of good visual outcome after cataract surgery fades. In these cases, a final BCVA of 20/30 or better is highly unlikely.

Jérôme C. Vryghem, MD, is from the Brussels Eye Doctors, in Brussels, Belgium. Dr. Vryghem states that he has no financial interest in the products or companies mentioned. He is a member of the CRST Europe Editorial Board. He may be reached at +32 2 741 69 99; j.c.vryghem@vryghem.be; info@vryghem.be.

1. Bertrand F, Delplace MP, Bertrand P. Interet de l'E.R.G et des P.E.V en rouge dans le pronostic preoperatoire des cataracts seniles. Bull Soc Ophthalmol Fr. 1984;84:1321-1324.
2. Sherman J, David E, Schnider C, et al. Presurgical prediction of postsurgical visual acuity in patients with media opacities. J Am Optom Assoc. 1988;59:481-488.
3. Wu D-z, Wu L, Zu X, et al. The significance of testing preoperative visual function in cataract using laser interferometric vusial acuity and ERG. Yen Ko Hsueh Pao. 1991;7:21-24.
4. Odom JV, Chao GM, Weinstein GW. Preoperative prediction of postoperative visual acuity in patients with cataracts: a quantitative review. Doc Ophthalmol. 1988;70:5-17.
5. Van Lith GHM, Hekkert-Wiebenga W. Cataract, pattern stimulation and visually evoked potentials. Doc Ophthalmol. 1983;55:107-112.
6. Kogure S, Iijima H, Tsukahara S. Assessment of potential macular function using a color saturation discrimination test in eyes with cataract. J Cataract Refract Surg. 1999;25:569-574.
7. Gringnolo FM, Moscone F, Sobrero C, Leone M. Evaluation of macular function by Lotmar's visometer test and blue-field entoptic test in patients with cataract. Ann Ophthalmol. 1988;20:247-250, 255.
8. Miris R, Missotten L. Evaluation of the macular function in cataractous eyes by means of the blue-field entoptoscope. Bull Soc Belge Ophthalmol. 1982;201:121-126.
9. Sinclair SH, Loebl M, Riva CE. Blue field entoptic phenomenon in cataract patients. Arch Ophthalmol. 1979;1092-1095.
10. Vryghem JC, Van Cleynenbreugel H, Van Calster J, Leroux K. Predicting cataract surgery results using a macular function test. J Cataract Refract Surg. 2004;30:2349-2353.

NEXT IN THIS ISSUE